PL2408446T3 - Zastosowanie kompozycji farmaceutycznych zawierających mesembrenon - Google Patents
Zastosowanie kompozycji farmaceutycznych zawierających mesembrenonInfo
- Publication number
- PL2408446T3 PL2408446T3 PL10710448T PL10710448T PL2408446T3 PL 2408446 T3 PL2408446 T3 PL 2408446T3 PL 10710448 T PL10710448 T PL 10710448T PL 10710448 T PL10710448 T PL 10710448T PL 2408446 T3 PL2408446 T3 PL 2408446T3
- Authority
- PL
- Poland
- Prior art keywords
- mesembrenone
- pharmaceutical compositions
- compositions containing
- pharmaceutical
- containing mesembrenone
- Prior art date
Links
- HDNHBCSWFYFPAN-IRXDYDNUSA-N Mesembrenone Chemical compound C1=C(OC)C(OC)=CC=C1[C@@]1(C=CC(=O)C2)[C@H]2N(C)CC1 HDNHBCSWFYFPAN-IRXDYDNUSA-N 0.000 title 1
- HDNHBCSWFYFPAN-UHFFFAOYSA-N mesembrenone Natural products C1=C(OC)C(OC)=CC=C1C1(C=CC(=O)C2)C2N(C)CC1 HDNHBCSWFYFPAN-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Oncology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Communicable Diseases (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ZA200902003 | 2009-03-20 | ||
| EP10710448.1A EP2408446B1 (en) | 2009-03-20 | 2010-03-16 | Use of pharmaceutical compositions containing mesembrenone |
| PCT/IB2010/051132 WO2010106494A1 (en) | 2009-03-20 | 2010-03-16 | Use of pharmaceutical compositions containing mesembrenone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2408446T3 true PL2408446T3 (pl) | 2020-03-31 |
Family
ID=42167479
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10710448T PL2408446T3 (pl) | 2009-03-20 | 2010-03-16 | Zastosowanie kompozycji farmaceutycznych zawierających mesembrenon |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8552051B2 (pl) |
| EP (1) | EP2408446B1 (pl) |
| AU (1) | AU2010224485B2 (pl) |
| DK (1) | DK2408446T3 (pl) |
| ES (1) | ES2759675T3 (pl) |
| PL (1) | PL2408446T3 (pl) |
| PT (1) | PT2408446T (pl) |
| WO (1) | WO2010106494A1 (pl) |
| ZA (1) | ZA201106703B (pl) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2010224486B2 (en) | 2009-03-20 | 2014-04-24 | Hg&H Pharmaceuticals (Pty) Ltd | Sceletium extract and uses thereof |
| GB201101075D0 (en) | 2011-01-21 | 2011-03-09 | Labminds Ltd | Automated solution dispenser |
| AU2012215606B2 (en) | 2011-02-07 | 2016-12-22 | Scipharm Sarl | Novel composition for the treatment of cystic fibrosis |
| MD20150071A2 (ro) | 2013-02-19 | 2016-02-29 | Pfizer Inc. | Compuşi azabenzimidazolici ca inhibitori ai PDE4 izoenzimelor pentru tratamentul tulburărilor SNC şi altor afecţiuni |
| CA2925318C (en) | 2013-09-27 | 2021-01-19 | Justin SHER | Nutraceutical composition for pde4 inhibition, enhanced dopamine metabolism and long term potentiation |
| US20170065653A1 (en) | 2014-02-28 | 2017-03-09 | Nature's Sunshine Products, Inc. | Phosphodiesterase Inhibiting Phytochemical Compositions |
| US10131669B2 (en) | 2014-07-24 | 2018-11-20 | Pfizer Inc. | Pyrazolopyrimidine compounds |
| HUE044040T2 (hu) | 2014-08-06 | 2019-09-30 | Pfizer | Imidazopiridazin vegyületek |
| GB2553672A (en) | 2015-02-06 | 2018-03-14 | Labminds Ltd | Automated solution dispenser |
| WO2017089347A1 (en) | 2015-11-25 | 2017-06-01 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods and pharmaceutical compositions for the treatment of braf inhibitor resistant melanomas |
| BR112019025578A2 (pt) | 2017-07-26 | 2020-06-16 | Hg&H Pharmaceuticals (Pty) Ltd | Mesembrenol e/ou mesembranol para profilaxia e tratamento de pacientes que sofrem de epilepsia e doenças associadas |
| US10864239B1 (en) | 2019-10-30 | 2020-12-15 | Plant Synergy Inc. | High yield extraction method for and products of kanna plants |
| WO2021086345A1 (en) * | 2019-10-30 | 2021-05-06 | Plant Synergy Inc. | High yield extraction method for and products of kanna plants |
| TW202325275A (zh) | 2021-10-29 | 2023-07-01 | 美商感覺中樞治療公司 | 治療性生物鹼化合物之遞送 |
| US12410128B1 (en) | 2022-04-15 | 2025-09-09 | Sensorium Therapeutics, Inc. | Therapeutic alkaloid compounds |
| WO2024207030A1 (en) * | 2023-03-28 | 2024-10-03 | Stellenbosch University | Composition comprising a sceletium extract and uses thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3604112A1 (de) | 1986-02-10 | 1987-08-13 | Bernhard Dr Janiak | Pflanzenextrakte von mesembryanthemaceen sowie solche enthaltende schaedlingsbekaempfungsmittel und arzneimittel |
| US6271001B1 (en) | 1995-03-23 | 2001-08-07 | Bio Polymers Pty. Ltd. | Cultured plant cell gums for food, pharmaceutical, cosmetic and industrial applications |
| ZA974576B (en) | 1996-06-04 | 1998-02-04 | Farmarc Nederland Bv | Pharmaceutical composition. |
| SE9804064D0 (sv) | 1998-11-25 | 1998-11-25 | A & Science Invest Ab | Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells |
| AU2001233156A1 (en) | 2000-02-01 | 2001-08-14 | Human Genome Sciences, Inc. | Bcl-2-like polynucleotides, polypeptides, and antibodies |
| GB0111579D0 (en) * | 2001-05-11 | 2001-07-04 | Holford & Associates Ltd | Oral supplement |
| US7323334B2 (en) | 2002-10-04 | 2008-01-29 | The Regents Of The University Of California | Screening and therapeutic methods relating to neurogenesis |
| US6969702B2 (en) * | 2002-11-20 | 2005-11-29 | Neuronova Ab | Compounds and methods for increasing neurogenesis |
| US20050009847A1 (en) | 2002-11-20 | 2005-01-13 | Goran Bertilsson | Compounds and methods for increasing neurogenesis |
| US20040185429A1 (en) | 2002-12-09 | 2004-09-23 | Judith Kelleher-Andersson | Method for discovering neurogenic agents |
| EP1622577A4 (en) | 2003-04-17 | 2007-09-26 | Univ Leland Stanford Junior | PREVENTION OF NEUROGENESE DEFICITES WITH ANTI-INFLAMMATORY AGENTS |
| US7763588B2 (en) | 2003-06-13 | 2010-07-27 | The Salk Institute For Biological Studies | Method for increasing cognitive function and neurogenesis |
| JP2007519393A (ja) | 2003-08-05 | 2007-07-19 | ユニバーシティー オブ フロリダ リサーチ ファンデーション， インク． | 神経系細胞アッセイ |
| CA2579756C (en) * | 2004-06-19 | 2013-04-30 | Human Biomolecular Research Institute | Modulators of central nervous system neurotransmitters |
| AU2010224486B2 (en) | 2009-03-20 | 2014-04-24 | Hg&H Pharmaceuticals (Pty) Ltd | Sceletium extract and uses thereof |
-
2010
- 2010-03-16 ES ES10710448T patent/ES2759675T3/es active Active
- 2010-03-16 WO PCT/IB2010/051132 patent/WO2010106494A1/en not_active Ceased
- 2010-03-16 DK DK10710448T patent/DK2408446T3/da active
- 2010-03-16 US US13/256,686 patent/US8552051B2/en active Active
- 2010-03-16 AU AU2010224485A patent/AU2010224485B2/en active Active
- 2010-03-16 PT PT107104481T patent/PT2408446T/pt unknown
- 2010-03-16 EP EP10710448.1A patent/EP2408446B1/en active Active
- 2010-03-16 PL PL10710448T patent/PL2408446T3/pl unknown
-
2011
- 2011-09-13 ZA ZA2011/06703A patent/ZA201106703B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2010224485A1 (en) | 2011-10-20 |
| EP2408446A1 (en) | 2012-01-25 |
| EP2408446B1 (en) | 2019-09-11 |
| DK2408446T3 (da) | 2019-12-09 |
| WO2010106494A1 (en) | 2010-09-23 |
| US20120041045A1 (en) | 2012-02-16 |
| AU2010224485B2 (en) | 2014-04-17 |
| ZA201106703B (en) | 2012-05-30 |
| US8552051B2 (en) | 2013-10-08 |
| ES2759675T3 (es) | 2020-05-11 |
| PT2408446T (pt) | 2019-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201106703B (en) | Use of pharmaceutical compositions containing mesembrenone | |
| PT2482812T (pt) | Composições farmacêuticas compreendendo bi-1356 e metformina | |
| HUE044981T2 (hu) | Gyógyszerkészítmény | |
| SG2014012462A (en) | Pharmaceutical compositions | |
| EP2379077A4 (en) | PHARMACEUTICAL COMPOSITION | |
| IL215497A0 (en) | Oxadiazile derivatives and pharmaceutical compositions containing them | |
| ZA201203719B (en) | Pharmaceutical compositions of sevelamer | |
| EP2552447A4 (en) | STABLE PHARMACEUTICAL COMPOSITION OF IMATINIB | |
| ZA201107122B (en) | Stable pharmaceutical compositions of diclofenac | |
| EP2515880A4 (en) | NEW PHARMACEUTICAL COMPOSITIONS OF RANOLAZINE | |
| PL2391353T3 (pl) | Kompozycje farmaceutyczne trimetazydyny | |
| ZA201200659B (en) | Pharmaceutical composition of isoniazid | |
| PL2471520T3 (pl) | Kompozycja farmaceutyczna lewetyracetamu | |
| GB0902648D0 (en) | Pharmaceutical compounds and compositions | |
| IL219018A (en) | Radzolid Pharmaceuticals and Uses | |
| EP2543373A4 (en) | PHARMACEUTICAL COMPOSITION OF LEVOAMLODIPINE COMPOUND | |
| GB0908317D0 (en) | Pharmaceutical compounds and compositions | |
| PL2407159T3 (pl) | Kompozycje farmaceutyczne olmesartanu | |
| ZA201107054B (en) | Use of atorvastatin lactols as medicaments | |
| PL2277511T3 (pl) | Kompozycje farmaceutyczne lewetiracetamu o przedłużonym uwalnianiu | |
| ZA201200531B (en) | Pharmaceutical composition of rifampicin | |
| PT2519261E (pt) | Composição farmacêutica líquida oral de nifedipina | |
| HU0900698D0 (en) | Pharmaceutical compositions of enhanced stability | |
| GB0903945D0 (en) | Pharmaceutical compounds and compositions | |
| GB0919055D0 (en) | Pharmaceutical compounds and compositions |